Aflac Incorporated's Q4 2025 results revealed a miss in adjusted earnings per share at $1.57, falling short of analysts' expectations by $0.12, while revenue hit $4.87 billion, exceeding estimates by $517 million. The firm plans to enhance its first-quarter dividend by 5.2%, reflecting confidence in its cash position. Despite the earnings shortfall, Aflac continues to solidify its leadership in the supplemental health insurance market with strategic share buybacks and partnerships aimed at future growth.